HEPION PHARMACEUTICALS, INC. Repayments of Convertible Debt
HEPION PHARMACEUTICALS, INC. (HEPA) reported Repayments of Convertible Debt of $1.12 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2021-03-31
- HEPION PHARMACEUTICALS, INC. repayments of convertible debt for the quarter ending 2019-12-31 was $333.66K.
- HEPION PHARMACEUTICALS, INC. repayments of convertible debt for the quarter ending 2019-09-30 was $482.20K.
- HEPION PHARMACEUTICALS, INC. repayments of convertible debt for fiscal 2019 was $1.12M.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2019-12-31 | $333.66K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $815.86K derived: sum of 2 quarters · filed 2021-03-31 | $1.12M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $482.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $785.74K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $303.55K 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |